• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Cardiovascular
  • Randomized, Double-Blind, multicenter, trial to assess the effect of high & Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.

Disease
hypercholesterolaemia, diabetes type 2, dyslipidaemia
Drug Name
Crestor
Generic Name
rosuvastatin
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
III
Start Date
Jan 6, 2000
Study Name
D3560C00004
Study Id
D3560C00004
ClinicalTrials.gov ID
Not Applicable
Recruiting Status
Closed
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013